The wise choice for your eyes… since 2007

CLINICAL STUDY

Independent Study finds specific Amino Acids and Anti-Oxidants provide targeted support for those who suffer from IOP and Glaucoma.

Study: Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants
Publication: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1447-58. doi: 10.1167/iovs.07-1361.
Date published: January 24, 2022
Authors: Yuan He 1, Kar Wah Leung, Yue-Hong Zhang, Shan Duan, Xiu-Feng Zhong, Ru-Zhang Jiang, Zhan Peng, Joyce Tombran-Tink, Jian Ge
Summary: This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally noted is that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients. A key suspect in the progression of POAG is local oxidative stress. Oxidative free radicals and reactive oxygen species (ROS) are reported to trigger degeneration in the trabecular meshwork, subsequently leading to increases in IOP and glaucoma.

“Reversing oxidation may facilitate a healing response in the trabecular mesh-work or outflow pathway in the eyes of glaucoma patients.”

“There is nothing, that we know of, more effective than topically delivered N-acetyl-carnosine Can-C™ to reverse oxidation in the ocular environment” – Dr. Mark Babizhayev MA PhD

This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally noted is that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients.